Position
Creative Planning in Amneal Pharmaceuticals, Inc.
Back to the book · All holders of AMRX
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$8.96K$12.60 → $12.43
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 52.7K | $664.2K | — | — | — | 0.0% |
| Q1 2026 | 73.3K | $910.6K | $12.43 | −$8.96K | $255.4K | 0.0% |